Translate
4d Molecular Therapeutics Inc
About
4d Molecular Therapeutics Inc (NASDAQ:FDMT) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 18 2026
4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones
Mar 16 2026
4DMT to Participate in Upcoming Investor Meetings
Feb 13 2026
4DMT Announces New Employment Inducement Grants
Feb 9 2026
4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD
Jan 7 2026
4DMT Provides Company Update and Anticipated Development Milestones for 2026
Financials
Revenue
$85.21 M
Market Cap
$502.35 M
EPS
-2.42